Market Overview:
The global ivermectin in veterinary use market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for meat and milk products, rising awareness about animal health, and growing concerns about zoonotic diseases. Ivermectin is an effective drug against parasites such as roundworms, heartworms, and threadworms in animals. It is available in oral and injectable formulations, which are administered depending on the type of parasite infestation. The cattle segment accounted for the majority share of the global ivermectin in veterinary use market in 2017 and is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030.
Product Definition:
Ivermectin is a medication used to kill parasites in animals. It is important in veterinary use because it can help prevent and treat parasitic infections, which can be harmful to animals.
Oral:
Oral is a form of medication given to animals. It can be given in various forms such as tablets, powders, solutions or injections. The most common type used in veterinary medicine is the powder which is usually mixed with feed and fed to the animal daily.
Injection:
Ivermectin is an injectable used in the treatment of heartworm, roundworm and hookworms. It works by killing the parasites by interrupting their blood circulation. Ivermectin injection is available in both pre-filled syringes and vials containing preservative to keep them stable for a longer time period.
Application Insights:
The cattle segment held the largest share of the global market in 2017. The product is used to treat and prevent heartwater, liver fluke, river blindness, onchoceriasis and filaria among other infections. It is also used for improving animal productivity by reducing disease-causing bacteria in animals such as pigs and cows. Moreover, it helps reduce inflammation caused by parasitic infection which results in lessening pain & suffering to animals.
Ivermectin has been proven effective against internal parasites such as nematodes (roundworms), cestodes (tapeworms) & acanthocephalans (spiny worms).
Regional Analysis:
North America was the largest market for global ivermectin in veterinary use, followed by Europe. The presence of well-established animal health infrastructure and high awareness among pet owners about parasitic diseases are some of the major factors contributing to the growth of this regional market. Moreover, increasing incidence of zoonotic diseases due to exposure to infected animals is also expected to drive demand for these drugs over the forecast period. For instance, River Blindness (ocular Larva Migrans) disease is a common cause for concern in North American countries such as Canada and U.S., where it caused an annual economic loss estimated between USD X million and 100 million every year since its discovery in 1868 until 1924 when it was eradicated from North America through mass medication campaigns using ivermectin drug products approved for human use against Onchocerciasis (river blindness).
Growth Factors:
- Increasing demand for meat and dairy products due to population growth and changing dietary habits in emerging countries is expected to drive the market for veterinary use of ivermectin.
- Rising awareness about the benefits of using ivermectin as a preventive measure against various animal diseases is anticipated to fuel market growth during the forecast period.
- Growing number of zoonotic diseases, which can be transmitted from animals to humans, is projected to create lucrative opportunities for players operating in the veterinary use of ivermectin market over the next few years.
- Proliferation of private clinics and hospitals that offer specialized services for animals is likely to boost demand for veterinary use of ivermectin in developed countries during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ivermectin in Veterinary Use Market Research Report
By Type
Oral, Injection
By Application
Cattle, Sheep, Swine, Horse, Others
By Companies
Merck, Huvepharma,Inc, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Durvet
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Ivermectin in Veterinary Use Market Report Segments:
The global Ivermectin in Veterinary Use market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cattle, Sheep, Swine, Horse, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Huvepharma,Inc
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Durvet
Highlights of The Ivermectin in Veterinary Use Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Cattle
- Sheep
- Swine
- Horse
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ivermectin in Veterinary Use Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ivermectin is a medication used to treat infections in animals. It is available as a tablet or injection. Ivermectin works by killing the bacteria that is causing the infection.
Some of the key players operating in the ivermectin in veterinary use market are Merck, Huvepharma,Inc, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Durvet.
The ivermectin in veterinary use market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ivermectin in Veterinary Use Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Ivermectin in Veterinary Use Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Ivermectin in Veterinary Use Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Ivermectin in Veterinary Use Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Ivermectin in Veterinary Use Market Size & Forecast, 2018-2028 4.5.1 Ivermectin in Veterinary Use Market Size and Y-o-Y Growth 4.5.2 Ivermectin in Veterinary Use Market Absolute $ Opportunity
Chapter 5 Global Ivermectin in Veterinary Use Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ivermectin in Veterinary Use Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ivermectin in Veterinary Use Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ivermectin in Veterinary Use Market Size Forecast by Applications
6.2.1 Cattle
6.2.2 Sheep
6.2.3 Swine
6.2.4 Horse
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ivermectin in Veterinary Use Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ivermectin in Veterinary Use Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ivermectin in Veterinary Use Analysis and Forecast
9.1 Introduction
9.2 North America Ivermectin in Veterinary Use Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ivermectin in Veterinary Use Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ivermectin in Veterinary Use Market Size Forecast by Applications
9.10.1 Cattle
9.10.2 Sheep
9.10.3 Swine
9.10.4 Horse
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ivermectin in Veterinary Use Analysis and Forecast
10.1 Introduction
10.2 Europe Ivermectin in Veterinary Use Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ivermectin in Veterinary Use Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ivermectin in Veterinary Use Market Size Forecast by Applications
10.10.1 Cattle
10.10.2 Sheep
10.10.3 Swine
10.10.4 Horse
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ivermectin in Veterinary Use Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ivermectin in Veterinary Use Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ivermectin in Veterinary Use Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ivermectin in Veterinary Use Market Size Forecast by Applications
11.10.1 Cattle
11.10.2 Sheep
11.10.3 Swine
11.10.4 Horse
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ivermectin in Veterinary Use Analysis and Forecast
12.1 Introduction
12.2 Latin America Ivermectin in Veterinary Use Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ivermectin in Veterinary Use Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ivermectin in Veterinary Use Market Size Forecast by Applications
12.10.1 Cattle
12.10.2 Sheep
12.10.3 Swine
12.10.4 Horse
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ivermectin in Veterinary Use Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ivermectin in Veterinary Use Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ivermectin in Veterinary Use Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ivermectin in Veterinary Use Market Size Forecast by Applications
13.10.1 Cattle
13.10.2 Sheep
13.10.3 Swine
13.10.4 Horse
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ivermectin in Veterinary Use Market: Competitive Dashboard
14.2 Global Ivermectin in Veterinary Use Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Huvepharma,Inc
14.3.3 Zoetis Services LLC
14.3.4 Boehringer Ingelheim International GmbH
14.3.5 Durvet